Plain-English translation of NCT04339270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing azithromycin, an antibiotic that may help people with severe chronic obstructive pulmonary disease (COPD) who experience frequent flare-ups. The study compares two different ways of deciding when to give patients the medication: one approach is based on your symptoms, while the other is based on the thickness and properties of your mucus. Researchers want to find out which approach helps reduce flare-ups and improves quality of life.
People with severe COPD often have repeated flare-ups that can be serious and require hospitalization. While antibiotics like this medication may help, doctors aren't sure about the best way to decide when and how to use them. This trial aims to find the most effective approach to reduce flare-ups and improve daily life for COPD patients.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups: one group receives the medication based on their symptoms, and the other based on their mucus characteristics. You would visit the clinic every three months for measurements including lung function tests, symptom assessments, mucus samples, and blood work to check biomarkers. The study monitors any flare-ups you experience, medication side effects, and how your quality of life changes throughout the study period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France